2,388
Views
31
CrossRef citations to date
0
Altmetric
Short Report

Motor palsies of cranial nerves (excluding VII) after vaccination

Reports to the US Vaccine Adverse Event Reporting System

, &
Pages 301-305 | Received 16 Sep 2013, Accepted 01 Nov 2013, Published online: 14 Nov 2013

References

  • Chou CH, Liou WP, Hu KI, Loh CH, Chou CC, Chen YH. Bell’s palsy associated with influenza vaccination: two case reports. Vaccine 2007; 25:2839 - 41; http://dx.doi.org/10.1016/j.vaccine.2006.10.006; PMID: 17084492
  • Baxter R, Toback SL, Sifakis F, Hansen J, Bartlett J, Aukes L, Lewis N, Wu X, Ambrose CS. A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of age. Vaccine 2012; 30:3053 - 60; http://dx.doi.org/10.1016/j.vaccine.2012.02.080; PMID: 22425787
  • Baxter R, Toback SL, Sifakis F, Hansen J, Bartlett J, Aukes L, Lewis N, Wu X, Ambrose CS. A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age. Vaccine 2012; 30:2989 - 98; http://dx.doi.org/10.1016/j.vaccine.2012.02.039; PMID: 22386746
  • Bardage C, Persson I, Ortqvist A, Bergman U, Ludvigsson JF, Granath F. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. BMJ 2011; 343:d5956; http://dx.doi.org/10.1136/bmj.d5956; PMID: 21994316
  • Alp H, Tan H, Orbak Z. Bell’s palsy as a possible complication of hepatitis B vaccination in a child. J Health Popul Nutr 2009; 27:707 - 8; http://dx.doi.org/10.3329/jhpn.v27i5.3783; PMID: 19902808
  • Sejvar JJ, Labutta RJ, Chapman LE, Grabenstein JD, Iskander J, Lane JM. Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004. [Erratum in: JAMA. 2005 Dec 28;294] [24] [:3092. JAMA. 2007 Oct 24;298] [16] JAMA 2005; 294:2744 - 50; http://dx.doi.org/10.1001/jama.294.21.2744; PMID: 16333010
  • Zhou W, Pool V, DeStefano F, Iskander JK, Haber P, Chen RT, VAERS Working Group. A potential signal of Bell’s palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. Pharmacoepidemiol Drug Saf 2004; 13:505 - 10; http://dx.doi.org/10.1002/pds.998; PMID: 15317028
  • Mutsch M, Zhou W, Rhodes P, Bopp M, Chen RT, Linder T, Spyr C, Steffen R. Use of the inactivated intranasal influenza vaccine and the risk of Bell’s palsy in Switzerland. N Engl J Med 2004; 350:896 - 903; http://dx.doi.org/10.1056/NEJMoa030595; PMID: 14985487
  • Couch RB. Nasal vaccination, Escherichia coli enterotoxin, and Bell’s palsy. N Engl J Med 2004; 350:860 - 1; http://dx.doi.org/10.1056/NEJMp048006; PMID: 14985482
  • Lewis DJ, Huo Z, Barnett S, Kromann I, Giemza R, Galiza E, Woodrow M, Thierry-Carstensen B, Andersen P, Novicki D, et al. Transient facial nerve paralysis (Bell’s palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin. PLoS One 2009; 4:e6999; http://dx.doi.org/10.1371/journal.pone.0006999; PMID: 19756141
  • Stowe J, Andrews N, Wise L, Miller E. Bell’s palsy and parenteral inactivated influenza vaccine. Hum Vaccin 2006; 2:110 - 2; PMID: 17012908
  • Lee GM, Greene SK, Weintraub ES, Baggs J, Kulldorff M, Fireman BH, Baxter R, Jacobsen SJ, Irving S, Daley MF, et al, Vaccine Safety Datalink Project. H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. Am J Prev Med 2011; 41:121 - 8; http://dx.doi.org/10.1016/j.amepre.2011.04.004; PMID: 21767718
  • Committee to Review Adverse Effects of Vaccines, Institute of Medicine. Adverse Effects of Vaccines: Evidence and Causality. Stratton KR, Ford A, Rusch E, and Wright E (eds). Washington, DC: Washington, DC: National Academy Press, 2011; http://www.iom.edu/Reports/2011/Adverse-Effects-of-Vaccines-Evidence-and-Causality.aspx
  • Williams SE, Pahud BA, Vellozzi C, Donofrio PD, Dekker CL, Halsey N, Klein NP, Baxter RP, Marchant CD, Larussa PS, et al. Causality assessment of serious neurologic adverse events following 2009 H1N1 vaccination. Vaccine 2011; 29:8302 - 8; http://dx.doi.org/10.1016/j.vaccine.2011.08.093; PMID: 21893148
  • Code of Federal Regulations. 21 CFR 600.80. US Government Printing Office, 2001.
  • Empirica™ Signal, Phase Forward, Waltham, Massachusetts.
  • Rosenthal S, Chen R. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health 1995; 85:1706 - 9; http://dx.doi.org/10.2105/AJPH.85.12.1706; PMID: 7503351
  • Sills JM, Tanner LA, Milstien JB. Food and Drug Administration monitoring of adverse drug reactions. Am J Hosp Pharm 1986; 43:2764 - 70; PMID: 3799612
  • Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. MMWR Surveill Summ 2003; 52:1 - 24; PMID: 12825543
  • Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, Wassilak SG. The Vaccine Adverse Event Reporting System (VAERS). Vaccine 1994; 12:542 - 50; http://dx.doi.org/10.1016/0264-410X(94)90315-8; PMID: 8036829
  • Ellenberg SS, Braun MM. Monitoring the safety of vaccines: assessing the risks. Drug Saf 2002; 25:145 - 52; http://dx.doi.org/10.2165/00002018-200225030-00001; PMID: 11945111
  • Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J 2004; 23:287 - 94; http://dx.doi.org/10.1097/00006454-200404000-00002; PMID: 15071280
  • Holmes JM, Mutyala S, Maus TL, Grill R, Hodge DO, Gray DT. Pediatric third, fourth, and sixth nerve palsies: a population-based study. Am J Ophthalmol 1999; 127:388 - 92; http://dx.doi.org/10.1016/S0002-9394(98)00424-3; PMID: 10218690
  • Brazis PW. Isolated palsies of cranial nerves III, IV, and VI. Semin Neurol 2009; 29:14 - 28; http://dx.doi.org/10.1055/s-0028-1124019; PMID: 19214929
  • U.S. Food and Drug Administration. FDA’s Sentinel Initiative. [cited 2013 Sep 16]. Available from: http://www.fda.gov/Safety/FDAsSentinelinitiative/ucm2007250.html
  • Centers for Disease Control and Prevention. Vaccine Safety Datalink (VSD). [cited 2013 Sep 16]. Available from: http://www.cdc.gov/vaccinesafety/activities/vsd.html
  • Centers for Disease Control and Prevention. Clinical Immunization Safety Assessment (CISA) Project. [cited 2013 Sep 16]. Available from: http://www.cdc.gov/vaccinesafety/Activities/cisa.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.